Literature DB >> 19791749

Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25.

Wei-Qiang Chen1, Nicol Siegel, Lin Li, Arnold Pollak, Markus Hengstschläger, Gert Lubec.   

Abstract

Stability of cell lines is the prerequisite for all in vitro research, but literature on the stability of protein expression over passages is limited. Determination of specific stability markers, karyotyping, and morphology may not provide full information on this subject. It was the aim of the study to test protein level fluctuations in a human amniotic fluid stem cell line from passages 5, 7, 11, and 25. While karyotype, cell cycle, apoptosis rate, and 10 markers for characterization of the cell line remained unchanged (carried out at passages 5 and 25), cell volume was increased at passage 25. Significant protein fluctuations were observed for signaling, antioxidant, guidance cue, proteasomal, connective tissue, cytoskeleton proteins, chaperones, a chloride channel, and prothymosin at passages 5, 7, 11, and 25. Herein, the use of this gel-based proteomic screen, checking protein stability for the characterization of cell lines in addition to corresponding published markers, is proposed, in particular when experiments are run over several passages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19791749     DOI: 10.1021/pr900630s

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

Review 1.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

Review 2.  Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Authors:  Jennifer Petsche Connell; Gulden Camci-Unal; Ali Khademhosseini; Jeffrey G Jacot
Journal:  Tissue Eng Part B Rev       Date:  2013-03-14       Impact factor: 6.389

3.  Amniotic fluid and amniotic membrane stem cells: marker discovery.

Authors:  Maria G Roubelakis; Ourania Trohatou; Nicholas P Anagnou
Journal:  Stem Cells Int       Date:  2012-06-03       Impact factor: 5.443

4.  Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis.

Authors:  Jurate Savickiene; Grazina Treigyte; Sandra Baronaite; Giedre Valiuliene; Algirdas Kaupinis; Mindaugas Valius; Audrone Arlauskiene; Ruta Navakauskiene
Journal:  Stem Cells Int       Date:  2015-08-17       Impact factor: 5.443

5.  Senescence-Associated Molecular and Epigenetic Alterations in Mesenchymal Stem Cell Cultures from Amniotic Fluid of Normal and Fetus-Affected Pregnancy.

Authors:  Jūratė Savickienė; Sandra Baronaitė; Aistė Zentelytė; Gražina Treigytė; Rūta Navakauskienė
Journal:  Stem Cells Int       Date:  2016-10-10       Impact factor: 5.443

6.  mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression.

Authors:  Andrea Preitschopf; Kongzhao Li; David Schörghofer; Katharina Kinslechner; Birgit Schütz; Ha Thi Thanh Pham; Margit Rosner; Gabor Jozsef Joo; Clemens Röhrl; Thomas Weichhart; Herbert Stangl; Gert Lubec; Markus Hengstschläger; Mario Mikula
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

7.  Three-dimensional migration of human amniotic fluid stem cells involves mesenchymal and amoeboid modes and is regulated by mTORC1.

Authors:  Margit Rosner; Markus Hengstschläger
Journal:  Stem Cells       Date:  2021-08-04       Impact factor: 5.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.